unknown
Stage
1
Investors
About
Alixia develops therapeutics targeting the tumor microenvironment to overcome cancer drug resistance by disrupting metabolic and inflammatory interactions within tumor ecosystems.
Explore Alixia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.